Edgewise gave two new non-executive employees options on 17,250 shares and restricted stock units for 8,626 shares. The awards can add shares and compensation costs, but the report describes hiring pay, not a change to business results.
The awards are part of pay for new hires and can add shares and compensation costs. The report gives no sales, drug-development, or other business update, so it does not change the picture for Edgewise.
Follow Edgewise Therapeutics, Inc. (EWTX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for EWTX